MeSH term
Frequency | Condition_Probility | Acute Disease | 2 | 0.0 |
Adult | 9 | 0.0 |
Bone Marrow Transplantation/*statistics & numerical data | 2 | 2.0 |
Comparative Study | 12 | 0.0 |
Cord Blood Stem Cell Transplantation/*statistics & numerical data | 2 | 2.0 |
Fetal Blood/transplantation | 2 | 2.0 |
Humans | 147 | 0.0 |
Leukemia/*therapy | 2 | 1.0 |
Patient Selection | 2 | 1.0 |
Aged | 4 | 0.0 |
Time Factors | 6 | 0.0 |
Female | 14 | 0.0 |
Animals | 90 | 0.0 |
Antigens, Differentiation/genetics/metabolism | 2 | 15.0 |
Cell Compartmentation | 2 | 0.0 |
Cell Line | 51 | 0.0 |
*CpG Islands | 2 | 2.0 |
DNA-Binding Proteins/*metabolism | 4 | 0.0 |
*Drosophila Proteins | 41 | 3.0 |
Lipopolysaccharides/*pharmacology | 14 | 3.0 |
Membrane Glycoproteins/*metabolism | 16 | 3.0 |
Mice | 58 | 0.0 |
Receptors, Cell Surface/*metabolism | 18 | 3.0 |
Receptors, Immunologic/genetics/metabolism | 2 | 10.0 |
Research Support, Non-U.S. Gov't | 96 | 0.0 |
Signal Transduction | 33 | 0.0 |
Antigens, CD14/metabolism | 3 | 2.0 |
Fibroblasts/immunology/metabolism/microbiology | 2 | 100.0 |
Lipopolysaccharides/*metabolism | 6 | 4.0 |
Membrane Glycoproteins/metabolism | 6 | 1.0 |
Receptors, Cell Surface/metabolism | 8 | 1.0 |
*Apoptosis | 3 | 0.0 |
Lipopolysaccharides/antagonists & inhibitors/*pharmacology | 2 | 11.0 |
*Membrane Glycoproteins | 2 | 0.0 |
Mutation | 5 | 0.0 |
NF-kappa B/*metabolism | 16 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 53 | 0.0 |
Antigens, Differentiation/genetics | 4 | 12.0 |
Antigens, Surface/genetics | 3 | 6.0 |
Cells, Cultured | 30 | 0.0 |
Genetic Vectors | 3 | 0.0 |
Membrane Glycoproteins/genetics/*physiology | 2 | 2.0 |
Mice, Inbred C3H | 5 | 0.0 |
Mice, Inbred C57BL | 19 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 7 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Receptors, Cell Surface/genetics/*physiology | 3 | 5.0 |
Receptors, Immunologic/genetics | 3 | 7.0 |
*Signal Transduction | 17 | 0.0 |
Transcription Factor AP-1/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 11 | 0.0 |
Antigens, Differentiation/genetics/*metabolism | 6 | 25.0 |
Cell Differentiation | 6 | 0.0 |
Male | 12 | 0.0 |
Receptors, Immunologic/genetics/*metabolism | 3 | 7.0 |
Up-Regulation | 4 | 0.0 |
Apoptosis | 4 | 0.0 |
Cell Lineage | 2 | 0.0 |
Models, Biological | 9 | 0.0 |
Transcription, Genetic | 6 | 0.0 |
Endotoxins/*toxicity | 2 | 9.0 |
Interferon Type II/*pharmacology | 5 | 1.0 |
Kinetics | 6 | 0.0 |
Lipopolysaccharides/*toxicity | 2 | 3.0 |
NF-kappa B/metabolism | 24 | 3.0 |
Tumor Necrosis Factor-alpha/genetics | 2 | 0.0 |
Antigens, Differentiation/*metabolism | 4 | 3.0 |
Enzyme Activation/drug effects | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Interleukin-1/*pharmacology | 5 | 1.0 |
Phosphorylation | 7 | 0.0 |
Protein Kinases/*metabolism | 7 | 2.0 |
Protein-Tyrosine Kinase/metabolism | 3 | 0.0 |
Receptors, Immunologic/*metabolism | 4 | 2.0 |
Receptors, Interleukin-1/*physiology | 5 | 35.0 |
*Gene Expression Profiling | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Membrane Glycoproteins/*genetics/*metabolism | 2 | 8.0 |
Middle Aged | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
Lipopolysaccharides/immunology | 4 | 3.0 |
NF-kappa B/immunology | 3 | 16.0 |
Peptidoglycan/immunology | 3 | 42.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Teichoic Acids/immunology | 2 | 33.0 |
Up-Regulation/immunology | 2 | 1.0 |
Antigens, Differentiation/immunology | 2 | 1.0 |
Membrane Glycoproteins/*immunology | 7 | 3.0 |
Models, Immunological | 3 | 1.0 |
Receptors, Cell Surface/*immunology | 6 | 7.0 |
Receptors, Immunologic/immunology | 3 | 2.0 |
Signal Transduction/*immunology | 8 | 2.0 |
Immunity | 2 | 3.0 |
Amino Acid Sequence | 26 | 0.0 |
Blotting, Western | 10 | 0.0 |
Cytoplasm/*metabolism | 2 | 1.0 |
Enzyme Activation | 8 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 5 | 0.0 |
Gene Deletion | 2 | 0.0 |
Genes, Reporter | 8 | 0.0 |
Interleukin-1/*metabolism | 6 | 7.0 |
JNK Mitogen-Activated Protein Kinases | 6 | 1.0 |
Luciferases/metabolism | 3 | 0.0 |
Molecular Sequence Data | 29 | 0.0 |
Plasmids/metabolism | 5 | 0.0 |
Precipitin Tests | 10 | 0.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
Protein Binding | 11 | 0.0 |
Protein Structure, Tertiary | 12 | 0.0 |
Proteins/*chemistry/*physiology | 2 | 50.0 |
Structure-Activity Relationship | 3 | 0.0 |
Transfection | 24 | 0.0 |
Antigens, Differentiation/metabolism | 14 | 11.0 |
Protein Kinases/metabolism | 9 | 2.0 |
Proteins/metabolism | 5 | 0.0 |
Receptors, Immunologic/metabolism | 11 | 7.0 |
Species Specificity | 2 | 0.0 |
TNF Receptor-Associated Factor 6 | 21 | 16.0 |
Antigens, Differentiation/*biosynthesis | 2 | 6.0 |
Child | 2 | 0.0 |
Gingiva/cytology/*immunology | 2 | 14.0 |
Interleukin-8/*biosynthesis | 2 | 3.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Receptors, Immunologic/*biosynthesis | 2 | 8.0 |
Receptors, Interleukin-1/*metabolism | 9 | 33.0 |
Signal Transduction/*physiology | 13 | 1.0 |
*Adaptor Proteins, Signal Transducing | 3 | 0.0 |
DNA-Binding Proteins/metabolism | 5 | 0.0 |
Gene Expression | 5 | 0.0 |
Interleukin-6/biosynthesis | 4 | 1.0 |
Mice, Knockout | 14 | 0.0 |
Antigens, Differentiation/genetics/*physiology | 2 | 12.0 |
CHO Cells | 3 | 0.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
Hamsters | 3 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Neisseria meningitidis/*immunology | 2 | 11.0 |
Receptors, Immunologic/genetics/*physiology | 2 | 11.0 |
Antigens, Differentiation/*physiology | 7 | 7.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
Membrane Glycoproteins/*physiology | 13 | 4.0 |
Proteins/*physiology | 3 | 1.0 |
Receptors, Cell Surface/*physiology | 13 | 6.0 |
Receptors, Immunologic/*physiology | 6 | 3.0 |
Cell Separation | 3 | 0.0 |
Cytokines/*physiology | 2 | 1.0 |
Escherichia coli/immunology | 2 | 2.0 |
Lipopolysaccharides/pharmacology | 13 | 1.0 |
Caspases/metabolism | 3 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Cloning, Molecular | 12 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Escherichia coli/metabolism | 5 | 1.0 |
Immunoblotting | 4 | 0.0 |
Interleukin-1/metabolism | 3 | 1.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 4 | 1.0 |
Down-Regulation | 2 | 0.0 |
Fungal Proteins/metabolism | 2 | 1.0 |
Genes, Dominant | 4 | 0.0 |
Hela Cells | 7 | 0.0 |
Proteins/*metabolism | 3 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
Antigens, CD14/*metabolism | 3 | 3.0 |
*Receptors, Interleukin-1 | 4 | 80.0 |
Tumor Necrosis Factor-alpha/biosynthesis | 5 | 0.0 |
Adaptor Proteins, Vesicular Transport/*physiology | 2 | 40.0 |
Blotting, Northern | 3 | 0.0 |
Carrier Proteins/metabolism | 3 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Heterozygote | 2 | 0.0 |
Ligands | 4 | 0.0 |
Macrophages/metabolism | 4 | 1.0 |
Polymerase Chain Reaction | 2 | 0.0 |
RNA, Messenger/metabolism | 8 | 0.0 |
*Immunity, Natural | 2 | 3.0 |
B-Lymphocytes/immunology | 2 | 0.0 |
*Receptors, Immunologic | 29 | 18.0 |
Sequence Homology, Amino Acid | 12 | 0.0 |
Cytokines/metabolism | 4 | 0.0 |
Lipopolysaccharides/*immunology | 3 | 4.0 |
Antigens, Differentiation/physiology | 7 | 13.0 |
English Abstract | 3 | 0.0 |
Antigens, Differentiation/chemistry/metabolism | 2 | 40.0 |
Lipopolysaccharides/metabolism | 5 | 4.0 |
CpG Islands | 2 | 0.0 |
Dendritic Cells/immunology | 2 | 1.0 |
Receptors, Cell Surface/antagonists & inhibitors/metabolism/*physiology | 2 | 100.0 |
eIF-2 Kinase/physiology | 2 | 22.0 |
Receptors, Interleukin-1/immunology | 2 | 50.0 |
Analysis of Variance | 2 | 0.0 |
Gene Expression Regulation/drug effects | 3 | 0.0 |
Interleukin-8/biosynthesis | 2 | 1.0 |
Protein-Serine-Threonine Kinases/metabolism | 3 | 0.0 |
Base Sequence | 11 | 0.0 |
DNA Primers | 4 | 0.0 |
DNA, Complementary | 2 | 0.0 |
DNA-Binding Proteins/genetics/*immunology | 2 | 14.0 |
Genetic Complementation Test | 2 | 0.0 |
Receptors, Cell Surface/genetics/*immunology | 4 | 17.0 |
Reverse Transcriptase Polymerase Chain Reaction | 11 | 0.0 |
Cell Line, Transformed | 4 | 0.0 |
Protein Kinases/genetics/*metabolism | 3 | 3.0 |
Proteins/genetics/*metabolism | 4 | 0.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Proteins/physiology | 4 | 2.0 |
NF-kappa B/physiology | 2 | 2.0 |
Protein-Serine-Threonine Kinases/physiology | 2 | 2.0 |
Receptors, Interleukin-1/physiology | 2 | 20.0 |
Membrane Glycoproteins/chemistry/*metabolism | 3 | 9.0 |
Phenotype | 2 | 0.0 |
Receptors, Cell Surface/chemistry/*metabolism | 4 | 15.0 |
NF-kappa B/*physiology | 3 | 3.0 |
Protein Kinases/*physiology | 2 | 3.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Antigens, CD14/physiology | 2 | 5.0 |
Cytokines/*biosynthesis | 2 | 0.0 |
Drug Synergism | 3 | 0.0 |
Interleukin-8/secretion | 2 | 5.0 |
Membrane Glycoproteins/physiology | 3 | 1.0 |
Monocytes/*drug effects/metabolism | 2 | 2.0 |
Receptors, Cell Surface/physiology | 3 | 2.0 |
Signal Transduction/physiology | 4 | 0.0 |
Drosophila | 3 | 0.0 |
Models, Molecular | 5 | 0.0 |
Protein Conformation | 4 | 0.0 |
Receptors, Interleukin-1/chemistry/*metabolism | 2 | 50.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Receptors, Cell Surface/immunology | 2 | 5.0 |
Receptors, Interleukin-1/*immunology | 2 | 40.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Membrane Glycoproteins/genetics/*metabolism | 7 | 4.0 |
NF-kappa B/antagonists & inhibitors/*metabolism | 3 | 5.0 |
Receptors, Cell Surface/genetics/*metabolism | 7 | 5.0 |
Receptors, Interleukin-1/genetics/*metabolism | 3 | 100.0 |
Antigens, Differentiation/biosynthesis/genetics | 2 | 22.0 |
DNA/metabolism | 2 | 0.0 |
Gene Expression Regulation/*immunology | 3 | 2.0 |
Lymphocyte Activation/immunology | 2 | 0.0 |
Protein Binding/immunology | 2 | 1.0 |
Protein Biosynthesis | 5 | 0.0 |
Proteins/genetics | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 4 | 0.0 |
Sequence Alignment | 5 | 0.0 |
Membrane Glycoproteins/immunology/*physiology | 3 | 17.0 |
Receptors, Cell Surface/immunology/*physiology | 3 | 20.0 |
Membrane Glycoproteins/genetics/*immunology | 3 | 5.0 |
Interleukin-1/pharmacology | 5 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 4 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Signal Transduction/genetics/*immunology | 3 | 3.0 |
Adaptor Proteins, Vesicular Transport/metabolism | 2 | 13.0 |
*Multigene Family | 2 | 0.0 |
Antigens, CD14/biosynthesis | 3 | 4.0 |
Receptors, Interleukin-1/metabolism | 6 | 26.0 |
*Chromosomes, Human, Pair 3 | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Interleukin-1/*physiology | 2 | 2.0 |
Monocytes/drug effects/*metabolism | 2 | 1.0 |
Signal Transduction/*drug effects | 2 | 0.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
*Receptors, Cell Surface | 2 | 0.0 |
Transcription Factors/physiology | 3 | 1.0 |
*Antigens, Differentiation | 11 | 11.0 |
*Membrane Proteins | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Proteins/chemistry/genetics/*metabolism | 2 | 2.0 |
Apoptosis/*genetics | 2 | 0.0 |
Cytoplasm/metabolism | 3 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
*Mitogen-Activated Protein Kinases | 2 | 0.0 |
Dimerization | 4 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Proteins/*genetics | 3 | 0.0 |
Mammals | 2 | 0.0 |
Gene Expression Regulation | 5 | 0.0 |
Apoptosis/drug effects | 2 | 0.0 |
Monocytes/*cytology | 2 | 2.0 |
In Vitro | 3 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Trans-Activators/metabolism | 3 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Membrane Glycoproteins/chemistry/genetics/*metabolism | 2 | 8.0 |
Receptors, Interleukin/genetics | 2 | 6.0 |
Receptors, Interleukin-1/genetics | 3 | 25.0 |
Proteins/genetics/metabolism | 2 | 1.0 |
Cell Line, Tumor | 5 | 0.0 |
Interferon-alpha/*pharmacology | 2 | 1.0 |
Gene Expression Profiling | 3 | 0.0 |
Receptors, Immunologic/physiology | 3 | 2.0 |
Carrier Proteins/physiology | 2 | 1.0 |
Protein Kinases/physiology | 2 | 4.0 |
*Chromosome Mapping | 2 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Genetics, Population | 2 | 0.0 |
Genome, Human | 2 | 0.0 |
Bacterial Proteins/immunology | 2 | 9.0 |
Flow Cytometry | 4 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Sequence Homology | 2 | 0.0 |
Interferon Type II/pharmacology | 3 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Tumor Necrosis Factor-alpha/metabolism | 2 | 0.0 |
Carrier Proteins/chemistry/*metabolism | 2 | 2.0 |
*Protein-Serine-Threonine Kinases | 3 | 0.0 |
Antigens, CD14/biosynthesis/genetics | 2 | 28.0 |
Protein Transport | 2 | 0.0 |
